Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew K. Fust currently holds 38,836 shares of ONYX PHARMACEUTICALS INC (ONXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew K. Fust has been a net seller of ONXX stock. They have purchased $205.6K and sold $14.8M worth of shares.
Matthew K. Fust's most recent insider trade was on Sep 26, 2025, when they sold 10,000 shares at $1.91 per share.
Matthew K. Fust serves as Executive at ONYX PHARMACEUTICALS INC (ONXX). They have executed 142 insider transactions totaling $15.0M over their tenure at the company.
Matthew K. Fust holds the position of Executive at ONYX PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Matthew K. Fust has shown a selling trading pattern, with $205.6K in total purchases and $14.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew K. Fust was on Mar 20, 2024, when they sold $796.3K worth of CRNX shares. This transaction involved 17,500 shares at $45.50 per share.
Matthew K. Fust currently owns 38,836 shares of ONYX PHARMACEUTICALS INC (ONXX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew K. Fust's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew K. Fust has 142 Form 4 filings on record as an insider at ONYX PHARMACEUTICALS INC.
Set alerts for Matthew K. Fust and 40,000+ other insiders.